John M Errico (John Errico)

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 4

Top Topics

Contrast Enhanced

Respiratory Syndrome Coronavirus

Monoclonal Antibody

Top Venues

Research square

Nature medicine

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Laura A VanBlargan, John M Errico, Peter J Halfmann, Seth J Zost, James E Crowe, Lisa A Purcell, Yoshihiro Kawaoka, Davide Corti, Daved H Fremont, Michael S. Diamond
An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies. Nature medicine 28 (3) (2022)
James Brett Case, Samantha Mackin, John M Errico, Zhenlu Chong, Emily A Madden, Bradley Whitener, Barbara Guarino, Michael Alexander Schmid, Kim Rosenthal, Kuishu Ren, Ha V Dang, Gyorgy Snell, Ana Jung, Lindsay Droit, Scott A Handley, Peter J Halfmann, Yoshihiro Kawaoka, James E Crowe, Daved H Fremont, Herbert W Virgin, Yueh-Ming Loo, Mark T Esser, Lisa A Purcell, Davide Corti, Michael S. Diamond
Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains. Nature communications 13 (1) (2022)
Rita E Chen, Emma S Winkler, James Brett Case, Ishmael D Aziati, Traci L Bricker, Astha Joshi, Tamarand L Darling, Baoling Ying, John M Errico, Swathi Shrihari, Laura A VanBlargan, Xuping Xie, Pavlo Gilchuk, Seth J Zost, Lindsay Droit, Zhuoming Liu, Spencer Stumpf, David Wang, Scott A Handley, W Blaine Stine, Pei-Yong Shi, Meredith E Davis-Gardner, Mehul S Suthar, Miguel Garcia Knight, Raul Andino, Charles Y Chiu, Ali H Ellebedy, Daved H Fremont, Sean P J Whelan, James E Crowe, Lisa Purcell, Davide Corti, Adrianus C M Boon, Michael S. Diamond
In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains. Nature 596 (7870) (2021)
Laura A VanBlargan, John M Errico, Peter Halfmann, Seth J Zost, James E Crowe, Lisa Purcell, Yoshihiro Kawaoka, Davide Corti, Daved H Fremont, Michael S. Diamond
An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies. Research square (2021)